1. Home
  2. SPRY vs PLSE Comparison

SPRY vs PLSE Comparison

Compare SPRY & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • PLSE
  • Stock Information
  • Founded
  • SPRY 2015
  • PLSE 2014
  • Country
  • SPRY United States
  • PLSE United States
  • Employees
  • SPRY N/A
  • PLSE N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • PLSE Medical/Dental Instruments
  • Sector
  • SPRY Health Care
  • PLSE Health Care
  • Exchange
  • SPRY Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • SPRY 1.1B
  • PLSE 1.2B
  • IPO Year
  • SPRY N/A
  • PLSE 2016
  • Fundamental
  • Price
  • SPRY $12.49
  • PLSE $23.57
  • Analyst Decision
  • SPRY Strong Buy
  • PLSE
  • Analyst Count
  • SPRY 4
  • PLSE 0
  • Target Price
  • SPRY $26.00
  • PLSE N/A
  • AVG Volume (30 Days)
  • SPRY 1.4M
  • PLSE 127.7K
  • Earning Date
  • SPRY 03-20-2025
  • PLSE 03-27-2025
  • Dividend Yield
  • SPRY N/A
  • PLSE N/A
  • EPS Growth
  • SPRY N/A
  • PLSE N/A
  • EPS
  • SPRY N/A
  • PLSE N/A
  • Revenue
  • SPRY $2,568,000.00
  • PLSE N/A
  • Revenue This Year
  • SPRY $67,363.34
  • PLSE N/A
  • Revenue Next Year
  • SPRY $511.99
  • PLSE N/A
  • P/E Ratio
  • SPRY N/A
  • PLSE N/A
  • Revenue Growth
  • SPRY 8460.00
  • PLSE N/A
  • 52 Week Low
  • SPRY $6.29
  • PLSE $6.60
  • 52 Week High
  • SPRY $18.51
  • PLSE $23.62
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 44.57
  • PLSE 59.71
  • Support Level
  • SPRY $11.00
  • PLSE $17.35
  • Resistance Level
  • SPRY $14.87
  • PLSE $22.05
  • Average True Range (ATR)
  • SPRY 0.95
  • PLSE 1.22
  • MACD
  • SPRY 0.04
  • PLSE 0.26
  • Stochastic Oscillator
  • SPRY 31.26
  • PLSE 65.91

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: